Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$0.32.

  • Wave Life Sciences' EPS (Basic) rose 3191.49% to -$0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.65, marking a year-over-year increase of 4144.14%. This contributed to the annual value of -$0.7 for FY2024, which is 2991.59% down from last year.
  • According to the latest figures from Q3 2025, Wave Life Sciences' EPS (Basic) is -$0.32, which was up 3191.49% from -$0.31 recorded in Q2 2025.
  • Wave Life Sciences' EPS (Basic)'s 5-year high stood at $0.21 during Q4 2024, with a 5-year trough of -$0.86 in Q1 2021.
  • Over the past 5 years, Wave Life Sciences' median EPS (Basic) value was -$0.31 (recorded in 2025), while the average stood at -$0.35.
  • Within the past 5 years, the most significant YoY rise in Wave Life Sciences' EPS (Basic) was 24103.53% (2024), while the steepest drop was 77142.86% (2024).
  • Over the past 5 years, Wave Life Sciences' EPS (Basic) (Quarter) stood at -$0.61 in 2021, then rose by 26.23% to -$0.45 in 2022, then skyrocketed by 66.67% to -$0.15 in 2023, then skyrocketed by 241.04% to $0.21 in 2024, then tumbled by 251.26% to -$0.32 in 2025.
  • Its EPS (Basic) stands at -$0.32 for Q3 2025, versus -$0.31 for Q2 2025 and -$0.29 for Q1 2025.